Gui-Ling Chen

4PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyImmunogenetics (incl. genetic immunology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 27, 2026
QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects.

Zhen-Wei Shen, Qi Jiang, Kai-Qi Wu

|Jun 12, 2025
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study.

Zhen-Wei Shen, Ting-Han Jin, Kai-Qi Wu

|Jun 09, 2024
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study.

Zhen-Wei Shen, Kai-Qi Wu, Ting-Han Jin

|Jan 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.

Gui-Ling Chen, Yang Liu, Xue-Feng Gao

Pageof 1

Frequent Collaborators

1 joint publications

Zhen-Wei Shen